Medicare Enrolled

Dr. George Nissan, DO

Internal Medicine · Chicago, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1460 N HALSTED ST STE 501, Chicago, IL 60642
7733886390
In practice since 2005 (20 years)
NPI: 1245222033 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nissan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nissan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nissan

Dr. George Nissan is an internal medicine specialist in Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nissan performed 66 Medicare services across 36 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nissan received a total of $296,330 from 74 pharmaceutical and/or device companies across 1547 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nissan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 66 Medicare services $296,330 industry payments

Medicare Practice Summary

Medicare Utilization ↗
66
Medicare services
Bottom 6% in IL for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
36
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $58 $125
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
32 $81 $175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$296,330
Total received (2018-2024)
Avg $42,333/year across 7 years
Top 0% in IL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
1,547
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$246,506 (83.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$33,947 (11.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,877 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,333
2023
$36,173
2022
$48,108
2021
$41,070
2020
$37,623
2019
$68,960
2018
$59,063

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tonix Medicines, Inc.
$2,256
ABBVIE INC.
$1,305
Lundbeck LLC
$438
PFIZER INC.
$307
Lilly USA, LLC
$276
Teva Pharmaceuticals USA, Inc.
$271
Amgen Inc.
$113
REVANCE THERAPEUTICS, INC.
$105
Neurocrine Biosciences, Inc.
$92
Takeda Pharmaceuticals U.S.A., Inc.
$54
IDORSIA PHARMACEUTICALS US INC
$31
SCILEX PHARMACEUTICALS INC.
$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Bausch Health US, LLC
$17
Otsuka America Pharmaceutical, Inc.
$14
EVOKE PHARMA, INC.
$14
Top 3 companies account for 75.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$100,915
Amgen Inc.
$43,126
Teva Pharmaceuticals USA, Inc.
$34,232
ABBVIE INC.
$20,397
Biohaven Pharmaceutical Holding Company Ltd.
$15,333
Biohaven Pharmaceuticals, Inc.
$15,321
Assertio Therapeutics, Inc.
$12,759
BioDelivery Sciences International, Inc.
$10,091
Collegium Pharmaceutical, Inc.
$8,380
Lundbeck LLC
$7,505
Allergan Inc.
$5,169
Currax Pharmaceuticals LLC
$5,055
Promius Pharma LLC
$4,486
Tonix Medicines, Inc.
$2,256
MDD US Operations, LLC
$956
Merz Pharmaceuticals, LLC
$760
Supernus Pharmaceuticals, Inc.
$737
PFIZER INC.
$702
Novartis Pharmaceuticals Corporation
$579
Ipsen Biopharmaceuticals, Inc
$566
US WorldMeds, LLC
$461
Bausch Health US, LLC
$446
Avanir Pharmaceuticals, Inc.
$440
UCB, Inc.
$423
IMPEL PHARMACEUTICALS INC.
$383
AbbVie Inc.
$369
UPSHER-SMITH LABORATORIES LLC
$282
Genentech USA, Inc.
$279
Grifols USA, LLC
$266
Allergan, Inc.
$239
Merz North America, Inc.
$229
Sunovion Pharmaceuticals Inc.
$218
GENZYME CORPORATION
$216
EMD Serono, Inc.
$210
Biogen, Inc.
$182
Takeda Pharmaceuticals U.S.A., Inc.
$174
MERZ NORTH AMERICA, INC.
$142
Alexion Pharmaceuticals, Inc.
$132
Celgene Corporation
$132
Endo Pharmaceuticals Inc.
$130
Egalet US Inc
$117
ASSERTIO THERAPEUTICS, Inc.
$112
REVANCE THERAPEUTICS, INC.
$105
Upsher-Smith Laboratories LLC
$93
Neurocrine Biosciences, Inc.
$92
Harmony Biosciences LLC
$87
Vanda Pharmaceuticals Inc.
$82
Otsuka America Pharmaceutical, Inc.
$75
Eisai Inc.
$72
SK Life Science, Inc.
$68
Zyla Life Sciences
$63
Horizon Therapeutics plc
$59
Merck Sharp & Dohme LLC
$59
Scilex Pharmaceuticals Inc.
$52
ARBOR PHARMACEUTICALS, INC.
$51
Amneal Pharmaceuticals LLC
$45
Horizon Pharma plc
$42
Mallinckrodt Enterprises LLC
$37
Vertical Pharmaceuticals, LLC
$35
ARGENX US, INC.
$32
IDORSIA PHARMACEUTICALS US INC
$31
Shire North American Group Inc
$27
LivaNova USA, Inc.
$26
BANNER LIFE SCIENCES, LLC
$23
Axsome Therapeutics, Inc.
$22
SCILEX PHARMACEUTICALS INC.
$21
Acorda Therapeutics, Inc
$20
OptiNose US, Inc.
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Xeris Pharmaceuticals, Inc.
$14
Boston Scientific Corporation
$14
EVOKE PHARMA, INC.
$14
Alnylam Pharmaceuticals Inc.
$13
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 60.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APLENZIN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX - MIGRAINE · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Briviact · CAPLYTA · CONTRAVE · COPAXONE · Cambia · DAXXIFY · DUEXIS · DYSPORT · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · Enspryng · Entyvio · Fintepla · Fycompa · GAMMAGARD · GILENYA · GIMOTI · GVOKE PFS · Gamunex-C · Gralise · HETLIOZ · Horizant · INGREZZA · KESIMPTA · LEMTRADA · LORZONE · LYVISPAH · MAVENCLAD · MAYZENT · METHYLPHENIDATE 72 · MIGRANAL · MYOBLOC · Mavenclad · NASCOBAL · NORTHERA · NUEDEXTA · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONPATTRO · ONZETRA · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ozanimod · PAXLOVID · QUDEXY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RAYOS · REYVOW · RINVOQ · RYTARY · SKYRIZI · SOLIRIS · SPRIX · Soliris · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VIMOVO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XEOMIN · Xadago · Xeomin · Xhance · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in IL.

Looking for an internal medicine specialist in Chicago?
Compare internal medicine physicians in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
5,753
Per 100K population
110.9
County median income
$81,797
Nearest hospital
PRESENCE SAINTS MARY AND ELIZABETH MEDICAL CENTER
1.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nissan is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nissan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Nissan performed 34 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nissan receive payments from pharmaceutical companies?
Yes. Dr. Nissan received a total of $296,330 from 74 companies across 1,547 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nissan's costs compare to other internal medicine physicians in Chicago?
Dr. Nissan's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nissan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →